CWRU, UH researchers test noninvasive esophageal cancer screening technology
A multi-site study, backed by an $8 million NIH grant, will evaluate the effectiveness of Lucid Diagnostics' EsoCheck and ...
Targeted Oncology18h
Kato Breaks Down FDA Approval of Tislelizumab in Esophageal Cancer
Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.
Huron Daily Tribune on MSN2d
Coping with cancer: The Hallock family's story of strength and adaptation
According to Amanda, both children have faced challenges in adapting. Peyton is still grappling with the loss of another ...
Targeted Oncology1d
Experts Discuss Tislelizumab’s FDA Approval in Esophageal Cancer
Ken Kato, MD, PhD, and Harry H. Yoon, MD, MHS, discussed the recent FDA approval of tislelizumab in the first line for patients with esophageal squamous cell carcinoma.
RNA molecule identified as possible driver of gastric cancer
Researchers at Case Western Reserve University have discovered molecules that present the potential to drive the development ...
What Does Black Poop Say About Your Gut Health?
Discover the top causes of black poop like diet, supplements, and gut health conditions, plus the best treatment options ...
Healio2d
ACG revises gastric premalignancy guidelines to align with colon, esophagus surveillance
The ACG has revised its guidance for gastric premalignant conditions, such as atrophic gastritis, gastric intestinal ...
News-Medical.Net on MSN1d
Special class of RNA molecules may provide a new target to treat gastric cancer
Researchers at Case Western Reserve University have discovered molecules that present the potential to drive the development of gastric cancer-among the world's deadliest forms of the disease.
William Blair Comments on Genmab A/S FY2029 Earnings
Equities research analysts at William Blair issued their FY2029 earnings per share (EPS) estimates for shares of Genmab A/S ...